dds are that every person in the world knows, loves or is someone confronting cancer. In 2020 alone, cancer claimed the lives of roughly 10 million people globally and was responsible for more than 19 million diagnoses. Without bold and immediate action from the global health community, these numbers will continue to rise.
At Johnson & Johnson our innovative solutions have paved the way in oncology for more than 30 years, and we are determined to meet this public health crisis and transform cancer from a deadly disease to one that is preventable and curable.
Our reach, resources, and network of connections across the Johnson & Johnson Family of Companies, academia, governments and other healthcare organizations are helping address unmet challenges in some of the deadliest cancers, developing novel and differentiated solutions within pharmaceuticals, medical devices and consumer health.
While it’s in our nature to challenge the status quo and strive for the seemingly unattainable, it’s our passion to help patients that drives us. Maintaining health and creating a sense of hope for all people impacted by cancer is what propels us to fight this disease at every stage—even before it starts. We will not stop until we have eliminated cancer.
Our leadership in oncology is rooted in heart, science and ingenuity, and driven by a palpable commitment to improve and transform the lives of patients facing a cancer diagnosis. We won’t stop until we get to cure.
I am inspired by our scientists who bring a relentless, innovative focus every day toward our vision of the elimination of cancer, and by the patients who are counting on us to get there.
I will continue to help the world beat nicotine addiction and free people from cigarette smoking, the leading cause of preventable disease, including lung cancer.
I collaborate with the best scientists outside our walls to accelerate breakthrough innovations that have the potential to prevent, treat, and even cure cancer.
I am committed to driving convergent R&D with our talented teams across Johnson & Johnson to help prevent, intercept and cure lung cancer with an aim of transforming the trajectory of this disease for millions of people.
I challenge our scientists and engineers across all Medical Devices R&D to work together and partner with our Janssen R&D colleagues to build innovative devices and solutions that detect, treat, and ultimately eradicate cancer.
The pandemic shows the importance of being able to prevent, intercept or cure diseases, to eliminate them rather than manage their consequences. At Johnson & Johnson, we are applying these principles to other diseases, including lung cancer. I look forward to a day when people know cancer from history books only.